As myeloproliferative neoplasms (MPNs) are a rare form of blood cancer, patients may not be aware of its effects. How do MPNs affect a patient’s quality of life, and what do your patients need to know?
Researchers characterized incidence and factors linked to cerebral venous thrombosis associated with myeloproliferative neoplasms.
Researchers found a high incidence of thromboembolic events in young patients with myeloproliferative neoplasms, especially polycythemia vera.
During a residential rehabilitation program, researchers interviewed participants to determine their supportive care and rehabilitation needs.
The updated criteria from IWG-MRT-ECNM extended previous criteria to describe organ-by-organ specific response and progression cut-offs.